These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1611170)

  • 21. [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
    Thomas F; Mebtouche B; Clavier H; Kalfon P
    Rev Pneumol Clin; 2000 Feb; 56(1):37-40. PubMed ID: 10740113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The treatment of candidemia.
    Cofsky RD
    N Engl J Med; 1995 Apr; 332(16):1101; author reply 1101-2. PubMed ID: 7898537
    [No Abstract]   [Full Text] [Related]  

  • 23. Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
    Myoken Y; Kyo T; Kohara T; Fujihara M; Sugata T; Mikami Y
    Clin Infect Dis; 2003 Jun; 36(11):1496-7. PubMed ID: 12766847
    [No Abstract]   [Full Text] [Related]  

  • 24. The treatment of candidemia.
    DiNubile MJ
    N Engl J Med; 1995 Apr; 332(16):1100-1; author reply 1101-2. PubMed ID: 7898536
    [No Abstract]   [Full Text] [Related]  

  • 25. The treatment of candidemia.
    Girmenia C; Martino P
    N Engl J Med; 1995 Apr; 332(16):1101; author reply 1101-2. PubMed ID: 7898538
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of a Candida albicans sepsis with a combination of flucytosine and fluconazole.
    Scheven M; Jünemann K; Schramm H; Hühn W
    Mycoses; 1992; 35(11-12):315-6. PubMed ID: 1302806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of candidemia.
    Meunier F
    N Engl J Med; 1994 Nov; 331(20):1371-2. PubMed ID: 7935710
    [No Abstract]   [Full Text] [Related]  

  • 28. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
    Colombo AL
    Braz J Infect Dis; 2000 Jun; 4(3):113-8. PubMed ID: 10934493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
    Clancy CJ; Staley B; Nguyen MH
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3496-8. PubMed ID: 17005842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of candidemia in critically ill surgical patients with intravenous fluconazole.
    Nolla-Salas J; León C; Torres-Rodríguez JM; Martín E; Sitges-Serra A
    Clin Infect Dis; 1992 Apr; 14(4):952-4. PubMed ID: 1576294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluconazole-resistant Candida albicans in an immunocompetent child.
    Hennequin C; Labenne M; Benkerrou M; Hambourg M
    Clin Infect Dis; 1994 Dec; 19(6):1179-80. PubMed ID: 7888572
    [No Abstract]   [Full Text] [Related]  

  • 32. [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].
    Manabe A; Ebihara Y; Saito A; Takahashi K; Hosoya R
    Rinsho Ketsueki; 1997 Aug; 38(8):669-73. PubMed ID: 9311273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for candidemia-related mortality at a medical center in central Taiwan.
    Cheng YR; Lin LC; Young TG; Liu CE; Chen CH; Tsay RW
    J Microbiol Immunol Infect; 2006 Apr; 39(2):155-61. PubMed ID: 16604249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
    Fong IW; Bannatyne RM; Cheng PC
    Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
    Ghannoum MA; Kim HG; Long L
    J Antimicrob Chemother; 2007 Mar; 59(3):556-9. PubMed ID: 17242032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
    Cancelas JA; Lopez J; Cabezudo E; Navas E; Garcia Laraña J; Jimenez Mena M; Diz P; Perez de Oteyza J; Villalon L; Sanchez-Sousa A
    Bone Marrow Transplant; 1994 Mar; 13(3):333-4. PubMed ID: 8199575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
    J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of candida septicaemia in a regional burn unit.
    Still JM; Belcher K; Law EJ
    Burns; 1995 Dec; 21(8):594-6. PubMed ID: 8747732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with caspofungin in the treatment of persistent fungemia in neonates.
    Natarajan G; Lulic-Botica M; Rongkavilit C; Pappas A; Bedard M
    J Perinatol; 2005 Dec; 25(12):770-7. PubMed ID: 16222348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluconazole and Candida krusei infections.
    Bignardi GE; Savage MA; Coker R; Davis SG
    J Hosp Infect; 1991 Aug; 18(4):326-7. PubMed ID: 1682374
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.